Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rix

Showing results (801-810 of 837) with videos related to

Pageof 84
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2024
Polymeric Microbubble Shell Engineering: Microporosity as a Key Factor to Enhance Ultrasound Imaging and Drug Delivery PerformanceMirjavad Moosavifar, Roman A Barmin, Elena Rama, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthasesKent T Symons, Phan M Nguyen, Mark E Massari, et al.
Nature Communications|August 16, 2017
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathwaysThuc M Le, Soumya Poddar, Joseph R Capri, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Journal of Medicinal Chemistry|April 17, 2015
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer XenograftsAndiliy Lai, Mehmet Kahraman, Steven Govek, et al.
Scandinavian Journal of Gastroenterology|May 5, 2017
The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohortSøren S Olesen, Jakob L Poulsen, Asbjørn M Drewes, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Protocol for the Houston Hospital-Based Violence Intervention ProgramAlexander Testa, Eresha Bluth, Latanya Monroe, et al.
Plos One|July 2, 2025
Protocol for the Houston Hospital-based violence intervention programAlexander Testa, Eresha Bluth, Latanya Monroe, et al.
Pageof 84

Showing results (801-810 of 837) with videos related to

Sort By:
Pageof 84
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2024
Polymeric Microbubble Shell Engineering: Microporosity as a Key Factor to Enhance Ultrasound Imaging and Drug Delivery PerformanceMirjavad Moosavifar, Roman A Barmin, Elena Rama, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthasesKent T Symons, Phan M Nguyen, Mark E Massari, et al.
Nature Communications|August 16, 2017
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathwaysThuc M Le, Soumya Poddar, Joseph R Capri, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Journal of Medicinal Chemistry|April 17, 2015
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer XenograftsAndiliy Lai, Mehmet Kahraman, Steven Govek, et al.
Scandinavian Journal of Gastroenterology|May 5, 2017
The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohortSøren S Olesen, Jakob L Poulsen, Asbjørn M Drewes, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Protocol for the Houston Hospital-Based Violence Intervention ProgramAlexander Testa, Eresha Bluth, Latanya Monroe, et al.
Plos One|July 2, 2025
Protocol for the Houston Hospital-based violence intervention programAlexander Testa, Eresha Bluth, Latanya Monroe, et al.
Pageof 84